Lung Cancer News

July 14, 2006

CuraGen and TopoTarget Initiate Trial in Mesothelioma

Filed under: Uncategorized — admin @ 3:00 am

CuraGen and TopoTarget Initiate Trial in Mesothelioma
International News Service, Australia - Jun 21, 2006 II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase inhibitor, for the treatment of a type of cancer called mesothelioma.

A rock and a hard place
Nature.com (subscription), UK - Jul 11, 2006 Malignant mesothelioma cancer of the lining of the chest or abdomen is associated with exposure to asbestos and tends to be rare.

Scots to rush through asbestos amendment
injurywatch, UK - Jun 28, 2006 of liability in such cases and permit the House of Commons to overturn a recent ruling in the House of Lords that might have seen mesothelioma sufferers have

Asbestos May Lead to Fines in Santa Ana
Los Angeles Times, CA - Jul 8, 2006 roofing products. Its health effects range from shortness of breath and coughing to an often fatal cancer known as mesothelioma. Air

A long wait for justice
Leeds Today, UK - Jun 14, 2006 Victims of resulting mesothelioma suffered debilitating symptoms of an illness which seriously limited and painfully claimed lives.

Cancer campaigner slams NICE decision on mesothelioma drug
injurywatch, UK - Jun 27, 2006 Cancer campaigner Cancerbackup is critical of the decision by NICE not to approve Alimta (Pemetrexed disodium) for mesothelioma sufferers in England and Wales.

Asbestos ruling to close pay-outs loophole
Scotsman, United Kingdom - Jun 21, 2006 The controversy over mesothelioma, an incurable cancer affecting the lining of the lungs, linked to exposure to asbestos, erupted last month when law lords

Category: Fairway Woods
Golf-Gear-Review.com (press release), PA - Jun 20, 2006 url] [urlequalshttp://phenterminez.milan.jp/q/tempur-pedic-pillows.html]free ringtones[/url] [urlequalshttp://freeringtonez.milan.jp/w/]Mesothelioma[/url] http

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress